IXC invex therapeutics ltd
Add to My Watchlist 2.27% ! 9.0¢

Ann: Invex Granted Type C Meeting with FDA, page-108

  1. ejjwj
    428 Posts.
    lightbulb Created with Sketch. 60
    clock Created with Sketch.
    08/06/21
    08:33
    Post #: 53705161
    Sidenote: The FDA just approved an anti-amyloid agent (aducanumab - Biogen) for the treatment of Alzheimer's disease, when much of the evidence suggests that it does not work. The message is that the FDA tends to cave to big pharma and crap on the little guy. Let's hope the trend doesn't continue.
    IXC Price at posting: 66.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS Update on exploration at Fosterville and Glenlogan
right-arrow Created with Sketch.
NEWS High-Grade Gold Discovery Extends 75m North at 8 Mile Drill Hole
right-arrow Created with Sketch.
NEWS Watch Exclusive Interviews with ASX Leaders
right-arrow Created with Sketch.
NEWS Kameelburg Niobium and REE mineralisation extends to 1,350 Meters
right-arrow Created with Sketch.
NEWS High-grade copper identified at Nejo Gold Project, Ethiopia
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.0¢ 		Change
0.002(2.27%) 		Mkt cap ! $6.763M
Open High Low Value Volume
8.8¢ 9.0¢ 8.8¢ $8.48K 95K

Buyers (Bids)

No. Vol. Price($)
1 42086 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 11.50am 18/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.